Clinical Trials Directory

Trials / Unknown

UnknownNCT01566617

Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease

Impact of The Pharmaceutical Care on the Quality of Life of Patients With Chagas Disease and Heart Failure: Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
Evandro Chagas Institute of Clinical Research · Academic / Other
Sex
All
Age
18 Years – 76 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that pharmaceutical care may constitute an important tool for the clinical management of these patients by improving their compliance to their treatment with consequent improvement in their quality of life by minimizing symptoms, and decreasing the number of hospital admissions and adverse drug reactions. Therefore, the aim of this trial is to evaluate the contribution of pharmaceutical care to clinical treatment of patients with Chagas heart disease complicated by heart failure. Study Type: Interventional Study Design: A total of 88 patients will be randomly assigned into two parallel groups: (1) group who will receive standard care and pharmaceutical care; and (2) group who will receive only standard care. Both groups will be subjected to a follow-up period of 12 months. The primary outcome of this trial is the evaluation of quality of life, measured by the 36-item short-form and the Minnesota Living with Heart Failure Questionnaire. Secondary outcomes include drug-related problems and exercise tolerance measured by the standard six-minute walk test.

Conditions

Interventions

TypeNameDescription
OTHERStandard care and Pharmaceutical carePharmaceutical care is the direct interaction between the pharmacist and the drug's users in order to improve the therapeutic compliance among outpatients and promote adequate pharmacotherapeutic follow-up.
OTHERStandard careThese patients will only receive standard care, with out follow-up by the pharmacist

Timeline

Start date
2012-10-01
Primary completion
2017-01-01
Completion
2017-03-01
First posted
2012-03-29
Last updated
2016-01-21

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01566617. Inclusion in this directory is not an endorsement.